Lattice Biologics Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LBLTF research report →
Price Chart
About the company
Lattice Biologics Ltd. is a biotechnology firm focused on developing, manufacturing, and commercializing biological products designed for bone regeneration. These solutions are utilized globally across dental, spinal, and general orthopedic indications.
- CEO
- Donna Medina
- IPO
- 2010
- HQ
- Belgrade, MT, US
Get TickerSpark's AI analysis on LBLTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $16.55K
- P/E
- -0.01
- Fwd P/E
- 0.01
- PEG
- -0.00
- P/S
- 0.01
- P/B
- -0.00
- EV/EBITDA
- -53.08
- Div Yield
- 0.00%
- Gross Margin
- 41.44%
- Op Margin
- -13.64%
- Net Margin
- -60.19%
- ROE
- 23.33%
- ROIC
- 13.09%
Latest fiscal year · YoY change
- Revenue
- $2.46M+12.6%
- Gross Profit
- $1.02M+8.3%
- Op Income
- $-336,000
- Net Income
- $-1,483,000-46.5%
- EPS
- $-0.01-34.3%
- OCF Growth
- +231.7%
- FCF Growth
- -151.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.14
- RSI (14)
- 52
- Avg Volume
- 411
No earnings-call transcripts are available for LBLTF yet.
- Free Float
- 63.2%
- Shares Outstanding
- 165.45M
- Float Shares
- 104.61M
Our LBLTF coverage
Recent articles, reports, and earnings notes.
No research on LBLTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LBLTF report →